Advertisement
New Zealand markets closed
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NZD/USD

    0.5941
    -0.0008 (-0.14%)
     
  • NZD/EUR

    0.5549
    +0.0009 (+0.16%)
     
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD

    2,349.60
    +7.10 (+0.30%)
     
  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • NZD/JPY

    94.0360
    +1.5400 (+1.66%)
     

Global Single Cell Analysis in Next-Generation Sequencing Markets 2022-2027: Increasing Number of Cells Profiled / Multi-omics Focus Products / Spatial/In situ Genomics & Transcriptomics

Company Logo
Company Logo

Dublin, June 30, 2022 (GLOBE NEWSWIRE) -- The "Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts, Secondary Research), 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Single Cell Analysis in Next-Generation Sequencing Markets report focuses on the market for single cell genomics products - the hardware, service of the hardware, software, and consumables including for the sequencing step and other types of downstream analysis.

It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market.

The competitive situation, deals, and products are covered in respective chapters. Historical data for 2021 is provided, with forecast data spanning 2022-2027.

ADVERTISEMENT

The report also provides the most current market research into single cell genomics and the companies that participate in this market.

Some of the key market trends covered in the report include the following:

  • Increasing number of cells profiled

  • Multi-omics focus, products

  • Spatial/in situ genomics, transcriptomics

  • Data analysis challenges; software and IT introductions

  • Convergence of technological advances

  • Litigation

Companies Profiled include:

  • 10X Genomics

  • Bio-Rad

  • Dolomite Bio

  • Fluidigm

  • Illumina

  • Mission Bio

  • Qiagen

  • Takara Bio

Key Topics Covered:

Chapter 1: Executive Summary

  • Single Cell Genomics Revenue Forecast, Instruments/Hardware vs. Consumables, 2021-2022 ($M)

  • Single Cell Genomics Market Share, Instruments/Hardware vs. Consumables, 2021-2022 (%)

  • Scope and Methodology

Chapter 2: Introduction

  • Introduction

  • Applications

  • Infectious Disease

  • Understanding Cancer with miRNAs

  • Atherosclerosis Research

  • Neurological

  • Market Trends

  • Increasing Numbers of Cells Analyzed

  • Significant Interest in Multi-omics

  • Spatial Transcriptomics, In Situ Techniques Gaining Traction

  • Data Analysis, Data Volumes, High Dimensionality Challenging

  • Convergence of Technological Advances

  • Litigation With Most Major Companies

  • Deals, Collaborations

Chapter 3: Market Analysis

  • Revenues Forecast

    • Single Cell Genomics Shares, Hardware vs. Consumables, 2021-2027 (%)

    • Single Cell Genomics Revenue Forecast, Hardware vs. Consumables, 2021-2027 ($M)

    • Single Cell Genomics Revenue Growth Rates, Hardware vs. Consumables, 2021-2027 (%)

    • Single Cell Genomics Market Revenues, Consumables and Instruments/Hardware, 2021-2027

  • Regional Shares

    • Single Cell Genomics Regional Shares, (North America, APAC, Europe, ROW), 2021

  • Competitive Analysis

    • Companies' Involvement in Single Cell Genomics Areas

  • Products

    • Selected Single Cell Genomics Products/ Technologies

    • Selected Single Cell Genomics Product Introductions

Chapter 4: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/wbojuz

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900